Document Detail


Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes.
MedLine Citation:
PMID:  20489415     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Large randomised studies have established that early intensive glycaemic control reduces the risk of diabetic complications, both microvascular and macrovascular. However, epidemiological and prospective data support a long-term influence of early metabolic control on clinical outcomes. This phenomenon has recently been defined as 'metabolic memory'. Furthermore, evidence suggests that 'glucose variability' may also be an independent risk factor for cardiovascular complications in diabetes. Studies suggest that all these different situations of hyperglycaemia share a common pathogenetic mechanism, increased oxidative stress, producing an endothelial dysfunction. The therapeutic challenge derived from these evidences is a need not only for an early tight glycaemic control, but also for maintaining glycaemia within a strict normal narrow range.
Authors:
Antonio Ceriello
Related Documents :
16357805 - Increased plasma levels of n-terminal brain natriuretic peptide (nt-probnp) in type 2 d...
15258325 - Disturbances of haemostasis in diabetes mellitus.
3084605 - Total parenteral nutrition in patients with insulin-requiring diabetes mellitus.
15866065 - Should minimal blood glucose variability become the gold standard of glycemic control?
22253535 - Glycemic control and anti-osteopathic effect of propolis in diabetic rats.
9001485 - A difficult case. childhood onset insulin dependent diabetes presenting with severe hyp...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  17 Suppl 1     ISSN:  1741-8275     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-21     Completed Date:  2010-08-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  S15-9     Citation Subset:  IM    
Affiliation:
Insititut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. aceriell@clinic.ub.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atherosclerosis / blood,  etiology,  physiopathology*,  prevention & control
Blood Glucose / metabolism*
Blood Vessels / metabolism,  physiopathology*
Cardiovascular Diseases / blood,  etiology,  physiopathology*,  prevention & control
Diabetic Angiopathies / blood,  etiology,  physiopathology*,  prevention & control
Evidence-Based Medicine
Humans
Hyperglycemia / blood,  complications,  physiopathology*,  therapy
Oxidative Stress
Risk Assessment
Risk Factors
Chemical
Reg. No./Substance:
0/Blood Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reducing cardiovascular risk in patients with type 2 diabetes mellitus.
Next Document:  Diabetic dyslipidemia: extending the target beyond LDL cholesterol.